Management of post cardiac transplantation immunosuppression and COVID-19: A case report.

ABSTRACT:

Background

There is very limited experience in management of heart transplant (HT) recipients and their immunosuppressive drug therapies while confronted with a SARS-CoV-2 infection.

Case details

We report the case of a 60-year-old male, heart transplant recipient patient, admitted in our ICU for severe COVID-19. His immunosuppressors were discontinued. He presented an ARDS, a multiple organ failure and a refractory septic shock that eventually resulted in his death.

Discussion

Multiple studies reported a lower incidence of SARS-Cov-2 infection in HT recipients compared to the general population, probably due to their prior knowledge and use of protective and barrier measures; but when infected they tend to have poorer outcomes and higher fatality; on account of their

SUBMITTER: Melhaoui I 

PROVIDER: S-EPMC8452461 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature